Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry

Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt